Chika Christianne Moreen Nababan
Medical Science Study Program, Medical Faculty of Udayana University

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Microbiota-based therapies for chronic kidney disease Dessy Natasha Ade Putri; Chika Christianne Moreen Nababan
Intisari Sains Medis Vol. 10 No. 1 (2019): (Available online 1 April 2019)
Publisher : DiscoverSys Inc.

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (753.462 KB) | DOI: 10.15562/ism.v10i1.239

Abstract

Background: Increasing prevalence of chronic kidney disease (CKD) worldwide has been concerned as a global public health issue because of the burden of adverse outcomes, including mortality. Gut microbiota can be used as a potential therapeutic target to slow the progression of CKD.Aim: This literature review aims to provide an in-depth review about the potency of microbiota-based therapy for CKD.Method: from 58 journals reviewed, 51 were found suitable as references for this paper. The keywords used are “gut microbiota,” “chronic kidney disease”, “prebiotic”, “probiotic” and “fecal microbiota transplantation” on selected search engines.Result: In general, it has shown that microbiota-based therapies do have potential therapeutic effect as it can improve inflammatory response, uremic toxin, insulin resistance and cardiovascular risk.Conclusion: Prebiotic, probiotic, fecal microbiota transplantation and novel therapies have shown beneficial effects in treating patients with CKD.